EL.PA EL

EL.PA ESSILORLUXOTTICA

Healthcare · Medical Instruments & Supplies

5 · Fair Momentum 2.0 · Weak Watch

154.40

+3.83%

About the company

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

2.59%
74.77%
4.00
70.8B
28.86
5.35
188.73

52-week range

154
low 138 high 324
Yield Growth Momentum Safety Value Health

Dividend deep dive

ESSILORLUXOTTICA (EL.PA) operates within the Medical Instruments & Supplies industry. The company's current dividend yield is 2.59% based on a market price of 154.4 EUR. This yield is above its 5-year high of 1.9%, which Yield Theory indicates as an "undervalued" status. Specific momentum, value, and overall rating scores are not available in the provided data. The company has a market capitalization of 70,772,686,848.0 EUR.

Dividend history

The company currently has a dividend streak of 0 years, with annual payments typically occurring in May. ESSILORLUXOTTICA has shown strong dividend growth with a 3-year dividend CAGR of 16.32% and a 5-year dividend CAGR of 27.99%. Annual dividends per share have progressed from 0.94 EUR in 2014 to 3.23 EUR in 2023. The dividend for 2024 and 2025 is projected at 3.95 EUR, indicating a flat dividend for these two years following previous increases.

Dividend safety

The dividend payout ratio stands at 74.77% of earnings, indicating a significant portion of earnings is used for dividend distribution. The company's debt-to-equity ratio is 38.36%.

Quantic · Free

Read the rest of the safety verdict

Plus the key risks and what to watch next — free, no card.

AI-generated from Quantic's dividend data · Updated 16 Oct 2026 · Information, not financial advice.

Price history

317 216 114 2021 2022 2023 2024 2025 2026 2020-10 · 119 2020-11 · 125 2020-12 · 114 2021-01 · 132 2021-02 · 136 2021-03 · 135 2021-04 · 139 2021-05 · 152 2021-06 · 156 2021-07 · 163 2021-08 · 162 2021-09 · 175 2021-10 · 173 2021-11 · 183 2021-12 · 163 2022-01 · 153 2022-02 · 163 2022-03 · 160 2022-04 · 147 2022-05 · 140 2022-06 · 149 2022-07 · 146 2022-08 · 137 2022-09 · 157 2022-10 · 173 2022-11 · 166 2022-12 · 164 2023-01 · 161 2023-02 · 162 2023-03 · 176 2023-04 · 165 2023-05 · 169 2023-06 · 179 2023-07 · 170 2023-08 · 162 2023-09 · 167 2023-10 · 171 2023-11 · 178 2023-12 · 178 2024-01 · 192 2024-02 · 205 2024-03 · 196 2024-04 · 205 2024-05 · 201 2024-06 · 212 2024-07 · 214 2024-08 · 213 2024-09 · 215 2024-10 · 230 2024-11 · 236 2024-12 · 266 2025-01 · 287 2025-02 · 265 2025-03 · 253 2025-04 · 245 2025-05 · 233 2025-06 · 261 2025-07 · 260 2025-08 · 276 2025-09 · 317 2025-10 · 309 2025-11 · 270 2025-12 · 258 2026-01 · 225 2026-02 · 198 2026-03 · 181 2026-04 · 175 2026-05 · 164 2026-06 · 164 2026-07 · 160 2026-08 · 146 2026-09 · 149 2026-10 · 154
Price

Dividend profile

Frequency
Annual
Growth (TTM)
+1.3%
CAGR 3y
+16.3%
+28.0%
0 years

(5-year)

Now 2.6%
0.7% avg 1.5% 1.9%

Payment calendar

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Dividend history

CAGR 3y +16.3% CAGR 5y +28.0%
14 15 16 17 18 19 20 21 22 23 24 25

Per-share dividend by year

Quantic · Free

Unlock valuation & strategy

Two DDM fair values, margin of safety, sector value rank, Dividend Yield Theory, doubling time and max drawdown.

Debt & leverage

38.4%
0.89
0.50
Debt vs cash
Debt Cash
Total debt
15.3B EUR
Total cash
1.9B EUR
5.9B EUR

Latest reported balance-sheet figures.

Appears in these lists

EL.PA qualifies for these curated dividend rankings.

Information, not financial advice.

Quantic · Free

Track EL.PA and your whole portfolio

Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →